Viral Hepatitis (A, B, C, D, E) Viral markers, Lab diagnosis, Prevention Mujhe ye competency conceptually detail me samjhao Exam ke according microbiology

Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Mujhe ab bahut comprehensive content mil gaya hai. Ab ek detailed, exam-oriented response likhta hoon in Hindi-English mix mein.

🦠 VIRAL HEPATITIS - Complete Microbiology Notes

(Exam-Oriented | Jawetz + Harrison's se)


πŸ“Œ OVERVIEW - Ek Nazar Mein

Viral hepatitis = Liver ki inflammation caused by specific hepatotropic viruses. 5 main viruses hain:
PropertyHAVHBVHCVHDVHEV
FamilyPicornaviridaeHepadnaviridaeFlaviviridaeDeltaviridaeHepeviridae
GenusHepatovirusOrthohepadnavirusHepacivirusDeltavirusOrthohepevirus
Genome+ssRNA (7.5 kb)Partial dsDNA (3.2 kb)+ssRNA (9.4 kb)-ssRNA (1.7 kb) circular+ssRNA (7.5 kb)
Envelope❌ Non-envelopedβœ… Envelopedβœ… Envelopedβœ… (HBsAg coat)❌ Non-enveloped
Size27-32 nm42 nm (Dane particle)50-60 nm35-37 nm27-34 nm
TransmissionFecal-oralParenteral/Sexual/VerticalParenteralParenteralFecal-oral
Chronicity❌ Neverβœ… 5-10% adultsβœ… 70-80%βœ… (superinfection)❌ Never (immunocomp. mein rare chronic)
Vaccineβœ… Availableβœ… Available❌ NoneHDV = HBV vaccine se rokein❌ (HEV 239 limited)
Incubation15-45 days30-180 days15-160 daysSame as HBV14-60 days
Mnemonics: "A aur E = Fecal-oral" | "B, C, D = Blood/Body fluids"

πŸ… HEPATITIS A VIRUS (HAV)

Virology:

  • Family: Picornaviridae, Genus: Hepatovirus
  • Non-enveloped, +ssRNA, 27-32 nm, cubic symmetry
  • Only 1 serotype - isliye vaccine effective hai
  • Stable: Acid (pH 1), ether, 60Β°C/1 hour tak stable
  • Inactivated by: Autoclaving (121Β°C/20 min), boiling (5 min), UV radiation, formalin, chlorine (10-15 ppm)

Pathogenesis:

  • Fecal-oral route se enters β†’ small intestine β†’ hepatocytes mein replicate β†’ cell-mediated immunity se liver damage (virus directly cytopathic nahi)
  • Viremia: Incubation period ke end mein
  • HAV particles stool mein jaundice se 2 weeks PEHLE aate hain

Clinical Features:

  • Acute self-limiting illness - NEVER chronic
  • 3 phases: Prodromal (anorexia, nausea, fever, dark urine) β†’ Icteric (jaundice) β†’ Recovery
  • Fulminant hepatitis bahut rare (<0.1%)

πŸ…‘ HEPATITIS B VIRUS (HBV) ⭐ (Most Important for Exam)

Virology:

  • Family: Hepadnaviridae
  • Dane particle (42 nm) = complete virion
    • Outer envelope: HBsAg (surface antigen) = Australia antigen (1964 Blumberg discovery)
    • Inner core (27 nm): HBcAg + HBeAg + HBV DNA + DNA polymerase (reverse transcriptase activity)
  • Partial dsDNA genome - 3.2 kb, circular
  • 4 open reading frames: S gene (surface), C gene (core + precore), P gene (polymerase), X gene
  • cccDNA (covalently closed circular DNA) = nuclear reservoir - chronicity ka basis

Antigens and Antibodies (MOST IMPORTANT for exam):

HBsAg (Surface Antigen):

  • First marker to appear (2-6 weeks before symptoms)
  • Indicates: Active HBV infection (acute OR chronic)
  • Persists >6 months = Chronic infection
  • Disappears with recovery
  • Australia antigen - Blumberg ne discover kiya (Nobel Prize 1976)

Anti-HBs (Antibody to Surface Ag):

  • Appears after HBsAg disappears (or after vaccination)
  • Indicates: Recovery + Immunity OR Vaccination
  • Window period = HBsAg gone, Anti-HBs not yet appeared - iss time sirf anti-HBc IgM positive hoga

HBcAg (Core Antigen):

  • NEVER detected in serum (only in liver biopsy)
  • But antibody (anti-HBc) is detectable

Anti-HBc:

  • IgM anti-HBc = Acute/Recent infection (including window period!)
  • IgG anti-HBc = Past infection or chronic infection
  • Anti-HBc IgM = Best marker for acute HBV infection

HBeAg (e Antigen):

  • Derived from pre-core region
  • Indicates: High replication, High infectivity
  • Present in early acute hepatitis and chronic active hepatitis
  • Seroconversion (HBeAg β†’ Anti-HBe) = Good prognostic sign

Anti-HBe:

  • Indicates decreasing viral replication
  • Low infectivity

HBV DNA:

  • Most sensitive marker of viral replication
  • PCR-based assay: detects as few as 10-100 virions/mL
  • Used for monitoring antiviral therapy

πŸ“Š Serological Patterns Table (EXAM MOST ASKED):

ConditionHBsAgAnti-HBsAnti-HBc (IgM)Anti-HBc (IgG)HBeAgAnti-HBe
Acute HBVβœ…βŒβœ…-βœ…βŒ
Window periodβŒβŒβœ…βœ…βŒ-
RecoveryβŒβœ…βŒβœ…βŒβœ…
Chronic activeβœ…βŒβŒβœ…βœ…βŒ
Chronic carrierβœ…βŒβŒβœ…βŒβœ…
Vaccination onlyβŒβœ…βŒβŒβŒβŒ
Past infectionβŒβœ…βŒβœ…βŒ-
Key Exam Trick: Vaccination mein sirf Anti-HBs hoga, anti-HBc NAHI - yahi vaccination ko past infection se alag karta hai!

HBV Mutations (Exam Important):

  • Pre-core mutant: Stop codon at nucleotide 1896 β†’ HBeAg nahi banta β†’ HBeAg-negative chronic hepatitis B with active disease - anti-HBe positive bhi ho sakta hai
  • Surface gene mutant: Vaccine escape mutants

πŸ…’ HEPATITIS C VIRUS (HCV)

Virology:

  • Family: Flaviviridae, Genus: Hepacivirus
  • Enveloped, +ssRNA, 9.4 kb genome
  • 6 major genotypes (1-6), 100+ subtypes - genotype 1 most common worldwide, India mein genotype 3
  • High mutation rate β†’ quasi-species β†’ vaccine development impossible
  • Envelope proteins E1 and E2 - hypervariable region (HVR1) mein mutations

Lab Diagnosis:

  • Anti-HCV (ELISA): Screening test - current ya past infection indicate karta hai
    • No IgM class assay of clinical value (unlike HAV/HBV)
    • 3rd/4th generation ELISA most sensitive
  • HCV RNA (PCR):
    • Qualitative: Confirms active infection, "window period" mein bhi positive
    • Quantitative (viral load): Treatment monitoring
    • Positive in 1-2 weeks after infection (vs anti-HCV takes 6-8 weeks)
  • HCV Genotyping: Treatment duration/regimen decide karne ke liye
  • RIBA (Recombinant Immunoblot Assay): Confirmatory test for anti-HCV

Key Points:

  • 70-80% chronicity - most common cause of chronic hepatitis globally
  • Most common cause of adult liver transplantation (HCV cirrhosis)
  • Extrahepatic manifestations: Cryoglobulinemia, membranoproliferative GN, lichen planus
  • Screening: All persons born 1945-1965 (USA baby boomer screening)

πŸ…“ HEPATITIS D VIRUS (HDV) - Delta Agent

Virology:

  • DEFECTIVE/SATELLITE VIRUS - cannot replicate alone
  • Needs HBsAg as its envelope (coat)
  • -ssRNA circular genome, 1.7 kb - smallest human RNA virus genome
  • Contains HDAg (delta antigen) - small (p24) and large (p27) forms
  • Only 1 serotype

Two Forms:

  1. Co-infection: HDV + HBV simultaneously β†’ Usually self-limiting, complete recovery
  2. Superinfection: HDV infects chronic HBV carrier β†’ Most severe! High risk of fulminant hepatitis and cirrhosis

Lab Diagnosis:

MarkerMeaning
Anti-HDV (IgM) + anti-HBc IgMCo-infection
Anti-HDV (IgG) + HBsAg positive (no IgM anti-HBc)Superinfection
HDV RNA (PCR)Active HDV replication
HDAgAcute infection (early, transient)

πŸ…” HEPATITIS E VIRUS (HEV)

Virology:

  • Family: Hepeviridae (pehle Calicivirus-like classify kiya tha)
  • Non-enveloped, +ssRNA, 7.5 kb
  • 4 major genotypes:
    • Genotype 1, 2: Humans only, endemic areas (India, Asia, Africa)
    • Genotype 3, 4: Zoonotic (pigs, deer, camels), non-endemic areas
  • India + Asia = Waterborne outbreaks (monsoon flooding ke baad!)

Special Features:

  • Pregnant women mein most dangerous - mortality 10-20% (vs 1-2% general population)
  • HAV jaisa dikhta hai clinically - fecal-oral, no chronicity (in immunocompetent)
  • No vaccine routinely available (HEV 239 = Hecolin - only China mein licensed)
  • Secondary person-to-person spread = RARE (HAV se different!)
  • Zoonotic reservoir = primarily pigs

Lab Diagnosis:

  • Anti-HEV IgM: Acute HEV infection
  • Anti-HEV IgG: Past infection / immunity
  • HEV RNA (PCR): Acute infection confirmation, especially in immunocompromised

πŸ”¬ LAB DIAGNOSIS - Summary Approach

Acute Hepatitis Workup:

Step 1: Anti-HAV IgM + HBsAg test karo
  β†’ Anti-HAV IgM (+) = Acute HAV
  β†’ HBsAg (+) = Acute/Chronic HBV

Step 2: Agar dono negative β†’
  β†’ Anti-HBc IgM check (window period HBV)
  β†’ Anti-HCV + HCV RNA (acute HCV)
  β†’ Anti-HEV IgM (HEV especially pregnancy/endemic area)

Step 3: Agar HBsAg (+) β†’ Anti-HDV check (severe/fulminant cases)

Chronic Hepatitis Workup:

  • HBsAg + Anti-HCV (primary screen)
  • If HBsAg (+): HBeAg, Anti-HBe, HBV DNA quantitative
  • If Anti-HCV (+): HCV RNA qualitative β†’ if positive, HCV RNA quantitative + genotype

Common Lab Methods:

TestMethod
HBsAgELISA (most common), RIA
Anti-HAV IgMELISA
HBV DNAReal-time PCR (most sensitive)
HCV RNAPCR (qualitative + quantitative)
Liver enzymes (ALT/AST)Biochemical (elevated in all hepatitis)
Anamnesis tip: ALT > AST in viral hepatitis (opposite of alcoholic hepatitis where AST:ALT > 2:1)

πŸ’‰ PREVENTION (Exam Important)

HAV Prevention:

  • Active immunization: Inactivated HAV vaccine (Havrix, Vaqta)
    • 2 doses: 0 and 6-12 months
    • 95% effective, protects for 20+ years
    • Killed virus vaccine (not live attenuated in routine use)
  • Passive immunization: Normal Immunoglobulin (IG) = pre/post-exposure
  • General: Safe water, sanitation, hand hygiene, food safety (heat >85Β°C/1 min)

HBV Prevention:

  • Active immunization (Most effective!): Recombinant HBsAg vaccine (Engerix-B, Recombivax)
    • 3 doses: 0, 1, 6 months schedule
    • Recombinant DNA vaccine = yeast mein HBsAg produce karte hain
    • Anti-HBs β‰₯10 mIU/mL = protective
    • WHO recommend: Universal infant vaccination
  • Post-exposure prophylaxis (PEP):
    • HBIG (Hepatitis B Immune Globulin) + HBV vaccine simultaneously (different sites)
    • Needlestick, sexual exposure, infants born to HBsAg(+) mothers
  • Birth dose: 1st dose within 24 hours of birth (for MTCT prevention)
  • HBIG alone for infants of HBsAg(+) mothers + complete vaccine series
Key Exam Point: HDV bhi HBV vaccine se rukta hai (kyunki HDV ko HBV ki zaroorat hoti hai). Lekin chronic HBV carriers ko HDV superinfection se vaccine protect NAHI karta.

HCV Prevention:

  • No vaccine available (due to high mutability, quasi-species)
  • Blood/plasma screening mandatory
  • Harm reduction: needle exchange programs for IV drug users
  • No HCIG available
  • Safe injection practices, infection control in healthcare settings

HEV Prevention:

  • Safe water supply, sewage treatment
  • No routine vaccine (HEV 239 / Hecolin - China only)
  • Pregnant women: Avoid travel to endemic areas
  • Cook pork thoroughly (genotypes 3, 4)

🎯 HIGH-YIELD EXAM POINTS (Quick Revision)

One-liners:

  1. Australia antigen = HBsAg (Blumberg, 1964) - Nobel Prize 1976
  2. Window period mein only anti-HBc IgM positive hota hai
  3. Dane particle = complete infectious HBV virion (42 nm)
  4. HBeAg = infectivity marker (high replication)
  5. Anti-HBs alone (no anti-HBc) = vaccination
  6. HDV = defective virus, needs HBsAg envelope
  7. Superinfection > Coinfection (severity mein) for HDV
  8. HCV = most common cause liver transplant in adults
  9. HEV = most dangerous in pregnancy (10-20% mortality)
  10. HAV, HEV = fecal-oral; never chronic
  11. HCV = 70-80% chronicity (highest)
  12. HBcAg serum mein NAHI milta - only in liver

Vaccine Comparison:

HAVHBVHCVHDVHEV
Vaccine typeInactivated/KilledRecombinant subunit❌Prevented by HBV vaccineLimited (China)

Chronicity Risk:

  • HBV: Perinatally acquired = 90% chronicity, Adults = 5-10%
  • HCV: 70-80% (any age)
  • HAV, HEV = Never chronic (HAV mein occasional relapsing hepatitis)

Sources: Jawetz, Melnick & Adelberg's Medical Microbiology 28e | Harrison's Principles of Internal Medicine 22e (2025)
This is a shared conversation. Sign in to Orris to start your own chat.